Cash and equivalents
Balance – as of period end · $M
Q2 2026
111$M
All values (11)
| Period | Value ($M) | Status |
|---|---|---|
| Q2 2026 | 111 | reported |
| Q1 2026 | 148 | reported |
| Q4 2025 | 168 | reported |
| Q3 2025 | 140 | reported |
| Q2 2025 | 162 | reported |
| Q1 2025 | 86 | reported |
| Q4 2024 | 80 | reported |
| Q3 2024 | 126 | reported |
| Q2 2024 | 421 | reported |
| Q1 2024 | 696 | reported |
| Q4 2023 | None | error |
31 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: cash
More metrics for Astera Labs
Income statement
Balance sheet
Revenue by segment/product/region
Sources & calculation
- Value
- $111M
- Period
- Q2 2026, ended Jun 30, 2026 · as of Jun 30, 2026 (balance as of date, not a sum)
- Source
- 10-Q, filed Aug 5, 2026 · 0001736297-26-000035
- Location
- us-gaap:CashAndCashEquivalentsAtCarryingValue
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | $111M | Aug 5, 2026 | 10-Q 0001736297-26-000035 | reported · confidence 1. · current |